Literature DB >> 17637755

p53-induced protein with a death domain (PIDD) isoforms differentially activate nuclear factor-kappaB and caspase-2 in response to genotoxic stress.

S Cuenin1, A Tinel, S Janssens, J Tschopp.   

Abstract

Cells respond to DNA damage in a complex way and the fate of damaged cells depends on the balance between pro- and antiapoptotic signals. This is of crucial importance in cancer as genotoxic stress is implied both in oncogenesis and in classical tumor therapies. p53-induced protein with a death domain (PIDD), initially described as a p53-inducible gene, is one of the molecular switches able to activate a survival or apoptotic program. Two isoforms of PIDD, PIDD (isoform 1) and LRDD (isoform 2), have already been reported and we describe here a third isoform. These three isoforms are differentially expressed in tissues and cell lines. Genotoxic stress only affects PIDD isoform 3 mRNA levels, whereas isoforms 1 and 2 mRNA levels remain unchanged. All isoforms are capable of activating nuclear factor-kappaB in response to genotoxic stress, but only isoform 1 interacts with RIP-associated ICH-1/CED-3 homologous protein with a death domain and activates caspase-2. Isoform 2 counteracts the pro-apoptotic function of isoform 1, whereas isoform 3 enhances it. Thus, the differential splicing of PIDD mRNA leads to the formation of at least three proteins with antagonizing/agonizing functions, thereby regulating cell fate in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637755     DOI: 10.1038/sj.onc.1210635

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

Review 1.  P53-induced protein with a death domain (PIDD): master of puppets?

Authors:  F J Bock; L Peintner; M Tanzer; C Manzl; A Villunger
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

2.  Degradomics reveals that cleavage specificity profiles of caspase-2 and effector caspases are alike.

Authors:  Magdalena Wejda; Francis Impens; Nozomi Takahashi; Petra Van Damme; Kris Gevaert; Peter Vandenabeele
Journal:  J Biol Chem       Date:  2012-07-23       Impact factor: 5.157

3.  Regulation of PIDD auto-proteolysis and activity by the molecular chaperone Hsp90.

Authors:  A Tinel; M J Eckert; E Logette; S Lippens; S Janssens; B Jaccard; M Quadroni; J Tschopp
Journal:  Cell Death Differ       Date:  2010-10-22       Impact factor: 15.828

Review 4.  The PIDDosome, DNA-damage-induced apoptosis and beyond.

Authors:  S Janssens; A Tinel
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

5.  Cutting edge: the "death" adaptor CRADD/RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes.

Authors:  Qing Lin; Yan Liu; Daniel J Moore; Sydney K Elizer; Ruth A Veach; Jacek Hawiger; H Earl Ruley
Journal:  J Immunol       Date:  2012-02-08       Impact factor: 5.422

6.  Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism.

Authors:  Nataly Shulga; Robin Wilson-Smith; John G Pastorino
Journal:  Cell Cycle       Date:  2009-10-19       Impact factor: 4.534

Review 7.  No death without life: vital functions of apoptotic effectors.

Authors:  L Galluzzi; N Joza; E Tasdemir; M C Maiuri; M Hengartner; J M Abrams; N Tavernarakis; J Penninger; F Madeo; G Kroemer
Journal:  Cell Death Differ       Date:  2008-02-29       Impact factor: 15.828

8.  Low expression of PIDD is associated with cell proliferation and apoptosis in hepatocellular carcinoma.

Authors:  Weidong Shi; Wei Huang; Yuyan Chen; Shusen Zhang; Pan Xu; Xiaoling Gu; Hui Fan; Jian Xu; Yongmei Chen; Runzhou Ni; Cuihua Lu; Xiubing Zhang
Journal:  Tumour Biol       Date:  2016-02-05

Review 9.  The enigma of caspase-2: the laymen's view.

Authors:  G Krumschnabel; B Sohm; F Bock; C Manzl; A Villunger
Journal:  Cell Death Differ       Date:  2008-11-21       Impact factor: 15.828

10.  Caspase-2 activation in the absence of PIDDosome formation.

Authors:  Claudia Manzl; Gerhard Krumschnabel; Florian Bock; Benedicte Sohm; Verena Labi; Florian Baumgartner; Emmanuelle Logette; Jürg Tschopp; Andreas Villunger
Journal:  J Cell Biol       Date:  2009-04-13       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.